Novel immunotherapeutic proteins immunoligand /

Novel immunotherapeutic proteins immunoligand /

Show other versions (2)
Saved in:
Bibliographic Details
Other Authors: Strom, T. B. (Terry B.) (Speaker), Zheng, Xin Xiao (Speaker)
Format: Electronic Video
Language:English
Published: London : Henry Stewart Talks, 2007.
Series:Henry Stewart talks. Biomedical & life sciences collection. Monoclonal antibodies as therapeutic agents : fundamentals, therapeutic applications and latest advances.
Subjects:
Antibodies, Monoclonal > therapeutic use.
Recombinant Fusion Proteins.
Online Access:https://hstalks.com/bs/596/
Series
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000ngm a2200000 a 4500
001 HST1288_1_2
003 UkLoHST
006 m c
007 cr|cna|||a||||
007 vz|czazum
008 080121s2007 enk|||||||||||s|||v|eng d
028 5 0 |a 1288  |b Henry Stewart Talks 
035 |a (UkLoHST)596 
035 |a (UkLU-K)AC000390572 
040 |a UkLU-K  |b eng  |c UkLU-K 
100 1 |a Strom, T. B.  |q (Terry B.)  |4 spk  |9 110797 
245 1 0 |a Novel immunotherapeutic proteins  |h [electronic resource] :  |b immunoligand /  |c Terry B. Strom, Xin Xiao Zheng. 
260 |a London :  |b Henry Stewart Talks,  |c 2007. 
300 |a 1 online resource (1 streaming video file (36 min.) :  |b color, sound). 
490 1 |a Monoclonal antibodies as therapeutic agents : fundamentals, therapeutic applications and latest advances,  |x 2056-452X 
500 |a Animated audio-visual presentation with synchronized narration. 
500 |a Title from title frames. 
505 0 |a Contents: Potential advantages of mAB -- Challenges for mAB -- Antibody based therapeutic proteins -- Attributes of immunoligands -- Creation of Ig-based fusion proteins -- Non-cytolytic IL-2/Fc fusion protein -- Vaccine trial design -- Creation of cytolytic IL-15R antagonist fusion protein -- Application of immunoligand: immunogen for mAB production, to stain the cognate ligand, to identify cell surface cognate ligands via immunoprecipitation, to create long lived proteins to test the function of the targeting ligand in vivo and to modulate immune responses -- Challenges for immunoligands. 
506 |a Access restricted to subscribers. 
538 |a Mode of access: World Wide Web. 
650 2 |a Antibodies, Monoclonal  |x therapeutic use.  |9 110798 
650 2 |a Recombinant Fusion Proteins.  |9 110799 
700 1 |a Zheng, Xin Xiao.  |4 spk  |9 110800 
830 0 |a Henry Stewart talks.  |p Biomedical & life sciences collection.  |p Monoclonal antibodies as therapeutic agents : fundamentals, therapeutic applications and latest advances.  |9 110801 
856 4 0 |u https://hstalks.com/bs/596/ 
856 4 2 |u https://hstalks.com/bs/p/30/  |3 Series 
999 |c 215979  |d 215978 

Similar Items